Total Payments
$47,735
2024 Payments
$17,885
Companies
20
Transactions
71
Medicare Patients
1,011
Medicare Billing
$137,620
Payment Breakdown by Category
Consulting$29,425 (61.6%)
Other$9,300 (19.5%)
Travel$7,821 (16.4%)
Food & Beverage$1,189 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $29,425 | 11 | 61.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,003 | 3 | 18.9% |
| Travel and Lodging | $7,821 | 24 | 16.4% |
| Food and Beverage | $1,189 | 32 | 2.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $297.39 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $25,737 | 28 | $0 (2024) |
| GENZYME CORPORATION | $6,207 | 3 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $5,902 | 3 | $0 (2024) |
| Genentech USA, Inc. | $5,756 | 7 | $0 (2018) |
| ABBVIE INC. | $2,888 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $549.93 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $194.86 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $110.11 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $81.51 | 2 | $0 (2023) |
| Tempus AI, Inc | $74.47 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,885 | 23 | PFIZER INC. ($11,364) |
| 2023 | $110.31 | 5 | Kite Pharma, Inc. ($28.63) |
| 2022 | $3,172 | 9 | ABBVIE INC. ($2,888) |
| 2021 | $6,125 | 1 | GENZYME CORPORATION ($6,125) |
| 2020 | $7,809 | 7 | PFIZER INC. ($7,809) |
| 2019 | $4,719 | 10 | PFIZER INC. ($4,476) |
| 2018 | $7,842 | 14 | Genentech USA, Inc. ($5,756) |
| 2017 | $74.17 | 2 | PFIZER INC. ($74.17) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $45.44 | General |
| 03/21/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $36.53 | General |
| 02/21/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $75.73 | General |
| 02/14/2019 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $230.72 | General |
| 01/28/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 12/11/2018 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $1,071.88 | General |
| 12/11/2018 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $636.34 | General |
| 12/11/2018 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $290.60 | General |
| 11/19/2018 | PFIZER INC. | RETACRIT (Biological) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: HEMATOLOGY | ||||||
| 05/22/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 05/09/2018 | Genentech USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| 05/09/2018 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $1,030.44 | General |
| 05/09/2018 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $291.58 | General |
| 05/09/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $104.84 | General |
| 05/09/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $83.81 | General |
| 05/09/2018 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $83.36 | General |
| 05/09/2018 | Genentech USA, Inc. | — | Food and Beverage | Cash or cash equivalent | $36.71 | General |
| 04/10/2018 | MEDIVATION FIELD SOLUTIONS LLC | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: ONCOLOGY | ||||||
| 03/02/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $56.03 | General |
| 04/27/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $44.42 | General |
| 04/27/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $29.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 349 | 13,724 | $251,647 | $47,340 |
| 2022 | 11 | 271 | 3,588 | $253,844 | $62,880 |
| 2021 | 6 | 152 | 351 | $39,144 | $18,529 |
| 2020 | 9 | 239 | 468 | $44,656 | $8,871 |
Total Patients
1,011
Total Services
18,131
Medicare Billing
$137,620
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 129 | $2,580 | $381.72 | 14.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 488 | $488.00 | $46.43 | 9.5% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 12 | 80 | $12,800 | $12,872 | 100.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 28 | $10,304 | $2,577 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 30 | $7,500 | $1,576 | 21.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 33 | 74 | $4,736 | $781.44 | 16.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 30 | 64 | $2,304 | $497.28 | 21.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 33 | 75 | $1,500 | $225.00 | 15.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 65 | $16,250 | $3,053 | 18.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 33 | $12,144 | $2,704 | 22.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 44 | 102 | $6,528 | $1,068 | 16.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 41 | 98 | $3,528 | $754.90 | 21.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $1,950 | $469.49 | 24.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 42 | 103 | $2,060 | $306.60 | 14.9% |
| 82728 | Ferritin (blood protein) level | Office | 2020 | 11 | 18 | $1,080 | $243.18 | 22.5% |
| 83550 | Iron binding capacity | Office | 2020 | 11 | 18 | $630.00 | $155.96 | 24.8% |
| 83540 | Iron level | Office | 2020 | 11 | 18 | $486.00 | $115.42 | 23.7% |
About Dr. Lalan Wilfong, MD
Dr. Lalan Wilfong, MD is a Medical Oncology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497793509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lalan Wilfong, MD has received a total of $47,735 in payments from pharmaceutical and medical device companies, with $17,885 received in 2024. These payments were reported across 71 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($29,425).
As a Medicare-enrolled provider, Wilfong has provided services to 1,011 Medicare beneficiaries, totaling 18,131 services with total Medicare billing of $137,620. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Hematology & Oncology
- Location Dallas, TX
- Active Since 06/02/2006
- Last Updated 04/07/2009
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1497793509
Products in Payments
- ELREXFIO (Drug) $9,465
- VENCLEXTA (Drug) $2,750
- NO PRODUCT DISCUSSED (Drug) $81.97
- XT CDX (Device) $74.47
- Trodelvy (Drug) $40.06
- SIR-Spheres Microspheres (Device) $33.15
- LUTATHERA (Drug) $25.48
- PADCEV (Biological) $25.30
- INJECTAFER (Drug) $24.48
- EPKINLY (Drug) $22.51
- KEYTRUDA (Biological) $20.93
- NERLYNX (Drug) $19.46
- Lenvima (Drug) $17.52
- SYNDROS (Drug) $15.86
- OPDIVO (Biological) $13.50
- BOSULIF (Drug) $12.76
- XTANDI (Drug) $11.54
- ELIQUIS (Drug) $11.49
- RETACRIT (Biological) $3.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Dallas
Dr. Moshe Levy, Md, MD
Medical Oncology — Payments: $5.0M
Medical Oncology $5.0M
Dr. Eric Nadler, Md, MD
Medical Oncology — Payments: $1.8M
Medical Oncology $1.8M
Dr. Joyce O'shaughnessy, Md, MD
Medical Oncology — Payments: $1.6M
Medical Oncology $1.6M
Dr. Thomas Hutson, Do,Pharmd, DO,PHARMD
Medical Oncology — Payments: $1.3M
Medical Oncology $1.3M
Dr. Tian Zhang, M.d, M.D
Medical Oncology — Payments: $395,066
Medical Oncology $395,066
Dr. Ashwani Agarwal, M.d, M.D
Medical Oncology — Payments: $304,262
Medical Oncology $304,262